FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2575951014> ?p ?o ?g. }

• W2575951014 endingPage "1064" @default.
• W2575951014 startingPage "1056" @default.
• W2575951014 abstract "Targeting of nanoparticles to distant diseased sites after oral delivery remains highly challenging due to the existence of many biological barriers in the gastrointestinal tract. Here we report targeted oral delivery of diverse nanoparticles in multiple disease models, via a “Trojan horse” strategy based on a bioinspired yeast capsule (YC). Diverse charged nanoprobes including quantum dots (QDs), iron oxide nanoparticles (IONPs), and assembled organic fluorescent nanoparticles can be effectively loaded into YC through electrostatic force-driven spontaneous deposition, resulting in different diagnostic YC assemblies. Also, different positive nanotherapies containing an anti-inflammatory drug indomethacin (IND) or an antitumor drug paclitaxel (PTX) are efficiently packaged into YC. YCs containing either nanoprobes or nanotherapies may be rapidly endocytosed by macrophages and maintained in cells for a relatively long period of time. Post oral administration, nanoparticles packaged in YC are first transcytosed by M cells and sequentially endocytosed by macrophages, then transported to neighboring lymphoid tissues, and finally delivered to remote diseased sites of inflammation or tumor in mice or rats, all through the natural route of macrophage activation, recruitment, and deployment. For the examined acute inflammation model, the targeting efficiency of YC-delivered QDs or IONPs is even higher than that of control nanoprobes administered at the same dose via intravenous injection. Assembled IND or PTX nanotherapies orally delivered via YCs exhibit remarkably potentiated efficacies as compared to nanotherapies alone in animal models of inflammation and tumor, which is consistent with the targeting effect and enhanced accumulation of drug molecules at diseased sites. Consequently, through the intricate transportation route, nanoprobes or nanotherapies enveloped in YC can be preferentially delivered to desired targets, affording remarkably improved efficacies for the treatment of multiple diseases associated with inflammation." @default.
• W2575951014 created "2017-01-26" @default.
• W2575951014 creator A5000005088 @default.
• W2575951014 creator A5004073477 @default.
• W2575951014 creator A5013697180 @default.
• W2575951014 creator A5015277544 @default.
• W2575951014 creator A5021541475 @default.
• W2575951014 creator A5027416136 @default.
• W2575951014 creator A5042037525 @default.
• W2575951014 creator A5054938833 @default.
• W2575951014 creator A5066186474 @default.
• W2575951014 creator A5069333404 @default.
• W2575951014 creator A5071551425 @default.
• W2575951014 creator A5079727471 @default.
• W2575951014 creator A5089390131 @default.
• W2575951014 date "2017-01-17" @default.
• W2575951014 modified "2023-10-16" @default.
• W2575951014 title "Yeast Microcapsule-Mediated Targeted Delivery of Diverse Nanoparticles for Imaging and Therapy via the Oral Route" @default.
• W2575951014 cites W1874889006 @default.
• W2575951014 cites W1905885715 @default.
• W2575951014 cites W1965097716 @default.
• W2575951014 cites W1973433801 @default.
• W2575951014 cites W1979507175 @default.
• W2575951014 cites W1983989992 @default.
• W2575951014 cites W1988940275 @default.
• W2575951014 cites W1997279783 @default.
• W2575951014 cites W1999732094 @default.
• W2575951014 cites W2003870922 @default.
• W2575951014 cites W2015370553 @default.
• W2575951014 cites W2017853225 @default.
• W2575951014 cites W2018755507 @default.
• W2575951014 cites W2023164440 @default.
• W2575951014 cites W2026250154 @default.
• W2575951014 cites W2026571103 @default.
• W2575951014 cites W2045075190 @default.
• W2575951014 cites W2045645253 @default.
• W2575951014 cites W2057391646 @default.
• W2575951014 cites W2064312734 @default.
• W2575951014 cites W2064472998 @default.
• W2575951014 cites W2067392670 @default.
• W2575951014 cites W2068664917 @default.
• W2575951014 cites W2070867977 @default.
• W2575951014 cites W2092877053 @default.
• W2575951014 cites W2093718909 @default.
• W2575951014 cites W2096616470 @default.
• W2575951014 cites W2097568210 @default.
• W2575951014 cites W2100820895 @default.
• W2575951014 cites W2107531246 @default.
• W2575951014 cites W2108093856 @default.
• W2575951014 cites W2138366383 @default.
• W2575951014 cites W2140333814 @default.
• W2575951014 cites W2143463421 @default.
• W2575951014 cites W2145756312 @default.
• W2575951014 cites W2151052889 @default.
• W2575951014 cites W2238193673 @default.
• W2575951014 cites W2346043912 @default.
• W2575951014 cites W2472521117 @default.
• W2575951014 cites W2530483728 @default.
• W2575951014 doi "https://doi.org/10.1021/acs.nanolett.6b04523" @default.
• W2575951014 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28075596" @default.
• W2575951014 hasPublicationYear "2017" @default.
• W2575951014 type Work @default.
• W2575951014 sameAs 2575951014 @default.
• W2575951014 citedByCount "91" @default.
• W2575951014 countsByYear W25759510142017 @default.
• W2575951014 countsByYear W25759510142018 @default.
• W2575951014 countsByYear W25759510142019 @default.
• W2575951014 countsByYear W25759510142020 @default.
• W2575951014 countsByYear W25759510142021 @default.
• W2575951014 countsByYear W25759510142022 @default.
• W2575951014 countsByYear W25759510142023 @default.
• W2575951014 crossrefType "journal-article" @default.
• W2575951014 hasAuthorship W2575951014A5000005088 @default.
• W2575951014 hasAuthorship W2575951014A5004073477 @default.
• W2575951014 hasAuthorship W2575951014A5013697180 @default.
• W2575951014 hasAuthorship W2575951014A5015277544 @default.
• W2575951014 hasAuthorship W2575951014A5021541475 @default.
• W2575951014 hasAuthorship W2575951014A5027416136 @default.
• W2575951014 hasAuthorship W2575951014A5042037525 @default.
• W2575951014 hasAuthorship W2575951014A5054938833 @default.
• W2575951014 hasAuthorship W2575951014A5066186474 @default.
• W2575951014 hasAuthorship W2575951014A5069333404 @default.
• W2575951014 hasAuthorship W2575951014A5071551425 @default.
• W2575951014 hasAuthorship W2575951014A5079727471 @default.
• W2575951014 hasAuthorship W2575951014A5089390131 @default.
• W2575951014 hasConcept C126511603 @default.
• W2575951014 hasConcept C15083742 @default.
• W2575951014 hasConcept C155672457 @default.
• W2575951014 hasConcept C171250308 @default.
• W2575951014 hasConcept C185592680 @default.
• W2575951014 hasConcept C192562407 @default.
• W2575951014 hasConcept C202751555 @default.
• W2575951014 hasConcept C203014093 @default.
• W2575951014 hasConcept C2776914184 @default.
• W2575951014 hasConcept C2778889443 @default.
• W2575951014 hasConcept C2779244956 @default.
• W2575951014 hasConcept C2779820397 @default.
• W2575951014 hasConcept C2780035454 @default.

• next